Objective Cervical cancer screening is very important in the prevention and treatment of
cervical cancer. In China, the cervical screening strategy needs to be improved. To explore a …

Purpose A high-risk human papillomavirus E6/E7 mRNA (HR-HPV mRNA) assay is widely
used in cervical cancer screening in China. However, it is still unclear whether stand-alone …

This study aims to evaluate the clinical performance of the HPV E6/E7 mRNA test in cervical
cancer screening in China. A hospital-based study was conducted with mRNA, DNA, and …

We conducted a cross-sectional analysis to assess the distribution of human papillomavirus
(HPV) types and explored an acceptable strategy for cervical screening in Shenzhen, China …

Cervical cancer poses a significant health challenge in developing countries, emphasizing
the need for appropriate screening strategies to accelerate the elimination of this disease …

Objectives The aim of the study was to evaluate the clinical performance of HBRT-H14, a
real-time PCR-based assay that separates human papillomavirus (HPV) 16 and HPV18 from …

Objectives The Cervista® high-risk human papillomavirus (HR-HPV) test was evaluated as a
primary screening method for cervical cancer in women aged≥ 21 years and was compared …

This study examined the efficacy of the OncoE6™ Cervical Test, careHPV™ and visual
inspection with acetic acid (VIA) in identifying women at risk for cervical cancer and their …

Objectives The objective of the present study is to assess the performance of a high-risk
human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a …

Cytology‐based cervical cancer screening is restricted because of a lack of cytologists.
Thus, HPV‐based instead of cytology‐based screening may be a more suitable strategy in …